TY - JOUR
T1 - Metabolic impact of adenovirus-mediated overexpression of the glucose- 6-phosphatase catalytic subunit in hepatocytes
AU - Seoane, Joan
AU - Trinh, Khiet
AU - O'Doherty, Robert M.
AU - Gómez-Foix, Anna M.
AU - Lange, Alex J.
AU - Newgard, Christopher B.
AU - Guinovart, Joan J.
PY - 1997
Y1 - 1997
N2 - Glucose-6-phosphatase (G6Pase) catalyzes the hydrolysis of glucose 6- phosphate (Glu-6-P) to free glucose and, as the last step in gluconeogenesis and glycogenolysis in liver, is thought to play an important role in glucose homeostasis. GSPase activity appears to be conferred by a set of proteins localized to the endoplasmic reticulum, including a glucose-6-phosphate translocase, a G6Pase phosphohydrolase or catalytic subunit, and glucose and inorganic phosphate transporters in the endoplasmic reticulum membrane. In the current study, we used a recombinant adenovirus containing the cDNA encoding the G6Pase catalytic subunit (AdCMV-G6Pase) to evaluate the metabolic impact of overexpression of the enzyme in primary hepatocytes. We found that AdCMV-G6Pase-treated liver cells contain significantly less glycogen and Glu-6-P, but unchanged UDP-glucose levels, relative to control cells. Further, the glycogen synthase activity state was closely correlated with Glu-6-P levels over a wide range of glucose concentrations in both G6Pase-overexpressing and control cells. The reduction in glycogen synthesis in AdCMV-G6Pase-treated hepatocytes is therefore not a function of decreased substrate availability but rather occurs because of the regulatory effects of Glu-6-P on glycogen synthase activity. We also found that AdCMV-G6Pase- treated-cells had significantly lower rates of lactate production and [3- 3H]glucose usage, coupled with enhanced rates of gluconeogenesis and Glu-6- P hydrolysis. We conclude that overexpression of the G6Pase catalytic subunit alone is sufficient to activate flux through the G6Pase system in liver cells. Further, hepatocytes treated with AdCMV-G6Pase exhibit a metabolic profile resembling that of liver cells from patients or animals with non- insulin-dependent diabetes mellitus, suggesting that dysregulation of the catalytic subunit of G6Pase could contribute to the etiology of the disease.
AB - Glucose-6-phosphatase (G6Pase) catalyzes the hydrolysis of glucose 6- phosphate (Glu-6-P) to free glucose and, as the last step in gluconeogenesis and glycogenolysis in liver, is thought to play an important role in glucose homeostasis. GSPase activity appears to be conferred by a set of proteins localized to the endoplasmic reticulum, including a glucose-6-phosphate translocase, a G6Pase phosphohydrolase or catalytic subunit, and glucose and inorganic phosphate transporters in the endoplasmic reticulum membrane. In the current study, we used a recombinant adenovirus containing the cDNA encoding the G6Pase catalytic subunit (AdCMV-G6Pase) to evaluate the metabolic impact of overexpression of the enzyme in primary hepatocytes. We found that AdCMV-G6Pase-treated liver cells contain significantly less glycogen and Glu-6-P, but unchanged UDP-glucose levels, relative to control cells. Further, the glycogen synthase activity state was closely correlated with Glu-6-P levels over a wide range of glucose concentrations in both G6Pase-overexpressing and control cells. The reduction in glycogen synthesis in AdCMV-G6Pase-treated hepatocytes is therefore not a function of decreased substrate availability but rather occurs because of the regulatory effects of Glu-6-P on glycogen synthase activity. We also found that AdCMV-G6Pase- treated-cells had significantly lower rates of lactate production and [3- 3H]glucose usage, coupled with enhanced rates of gluconeogenesis and Glu-6- P hydrolysis. We conclude that overexpression of the G6Pase catalytic subunit alone is sufficient to activate flux through the G6Pase system in liver cells. Further, hepatocytes treated with AdCMV-G6Pase exhibit a metabolic profile resembling that of liver cells from patients or animals with non- insulin-dependent diabetes mellitus, suggesting that dysregulation of the catalytic subunit of G6Pase could contribute to the etiology of the disease.
UR - http://www.scopus.com/inward/record.url?scp=0030856736&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0030856736&partnerID=8YFLogxK
U2 - 10.1074/jbc.272.43.26972
DO - 10.1074/jbc.272.43.26972
M3 - Article
C2 - 9341134
AN - SCOPUS:0030856736
SN - 0021-9258
VL - 272
SP - 26972
EP - 26977
JO - Journal of Biological Chemistry
JF - Journal of Biological Chemistry
IS - 43
ER -